Adaptive Biotechnologies ADPT Accrued Progress Collections and Price Adjustments
Accrued Progress Collections and Price Adjustments at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's accrued progress collections and price adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's accrued progress collections and price adjustments?
- Adaptive Biotechnologies (ADPT) reported accrued progress collections and price adjustments of $807K in Q1 2026.
- How has Adaptive Biotechnologies's accrued progress collections and price adjustments changed year-over-year?
- Adaptive Biotechnologies's accrued progress collections and price adjustments decreased by 96.7% year-over-year, from $24.81M to $807K.
- What is the long-term trend for Adaptive Biotechnologies's accrued progress collections and price adjustments?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's accrued progress collections and price adjustments has grown at a -63.9% compound annual growth rate (CAGR), from $163.62M to $1.01M.